Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
äŒæ¥ã³ãŒãFTRE
äŒç€ŸåFortrea Holdings Inc
äžå Žæ¥Jun 16, 2023
æé«çµå¶è²¬ä»»è
ãCEOãThakrala (Anshul)
åŸæ¥å¡æ°15500
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Jun 16
æ¬ç€Ÿæåšå°8 Moore Drive
éœåžDURHAM
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·27709
é»è©±çªå·18774950816
ãŠã§ããµã€ãhttps://www.fortrea.com/
äŒæ¥ã³ãŒãFTRE
äžå Žæ¥Jun 16, 2023
æé«çµå¶è²¬ä»»è
ãCEOãThakrala (Anshul)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã